Sthree Chemicals is an API manufacturer based in India. It holds 24 active US drug master files across a filed portfolio of 23 molecules. Customs aggregates show $4.1M of exports covering 52 molecules to 11 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Ranipet, India | 3028790835 |
| Molecule | Regulators | Docs |
|---|---|---|
| Tetracaine | US FDA | 2 |
| Avacopan | US FDA | 1 |
| Avatrombopag | US FDA | 1 |
| Biotin | US FDA | 1 |
| Calcium | US FDA | 1 |
| Cevimeline | US FDA | 1 |
| Cholic Acid | US FDA | 1 |
| Choline Salicylate | US FDA | 1 |
| Clemastine | US FDA | 1 |
| Enclomiphene | US FDA | 1 |
| Gatifloxacin | US FDA | 1 |
| Inositol | US FDA | 1 |
| Ketoconazole | US FDA | 1 |
| Lorazepam | US FDA | 1 |
| Methionine | US FDA | 1 |
| Naltrexone | US FDA | 1 |
| Nicotinamide | US FDA | 1 |
| Nicotinamide Riboside | US FDA | 1 |
| Oxcarbazepine | US FDA | 1 |
| Perampanel | US FDA | 1 |
| Risperidone | US FDA | 1 |
| Stanozolol | US FDA | 1 |
| Tafamidis | US FDA | 1 |
Also appears on these molecule pages
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $709K | 6 |
| 2025 | Not reported | $4.1M | 11 |
| 2024 | Not reported | $7.1M | 13 |
| 2023 | Not reported | $3.8M | 10 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Sthree Chemicals comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.